Cytopathogenic Effect, Viral
"Cytopathogenic Effect, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
| Descriptor ID |
D003588
|
| MeSH Number(s) |
E01.370.225.500.384.235 E05.200.500.384.235 E05.242.384.235 G06.920.190
|
| Concept/Terms |
Cytopathogenic Effect, Viral- Cytopathogenic Effect, Viral
- Cytopathic Effect, Viral
- Cytopathic Effects, Viral
- Effect, Viral Cytopathic
- Effects, Viral Cytopathic
- Viral Cytopathic Effect
- Viral Cytopathic Effects
- Viral Cytopathogenic Effect
- Cytopathogenic Effects, Viral
- Effect, Viral Cytopathogenic
- Effects, Viral Cytopathogenic
- Viral Cytopathogenic Effects
|
Below are MeSH descriptors whose meaning is more general than "Cytopathogenic Effect, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cytopathogenic Effect, Viral".
This graph shows the total number of publications written about "Cytopathogenic Effect, Viral" by people in this website by year, and whether "Cytopathogenic Effect, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 7 | 9 |
| 2005 | 1 | 3 | 4 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 3 | 3 |
| 2010 | 0 | 2 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2016 | 0 | 3 | 3 |
| 2017 | 2 | 6 | 8 |
| 2018 | 0 | 7 | 7 |
| 2019 | 2 | 2 | 4 |
| 2020 | 0 | 12 | 12 |
| 2021 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytopathogenic Effect, Viral" by people in Profiles.
-
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus. Viruses. 2021 08 23; 13(8).
-
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage. J Virol. 2021 10 13; 95(21):e0135721.
-
Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy. IUBMB Life. 2022 01; 74(1):93-100.
-
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions. J Am Soc Nephrol. 2021 09; 32(9):2242-2254.
-
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives. Virol J. 2021 06 09; 18(1):123.
-
Upregulation of INF-?, IL-6, and IL-8 expression during replication of turkey coronavirus in nonepithelial cells obtained from Meleagris gallopavo. Arch Virol. 2021 Aug; 166(8):2285-2289.
-
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Antiviral Res. 2021 07; 191:105089.
-
A Cytopathic Effect-Based Tissue Culture Method for HCoV-OC43 Titration Using TMPRSS2-Expressing VeroE6 Cells. mSphere. 2021 05 12; 6(3).
-
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2. Viruses. 2021 03 26; 13(4).
-
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat Commun. 2021 03 15; 12(1):1676.